A method of treating bacterial infections in a diabetic subject, said method comprising administrating high dose of Cephalosporin antibacterial agent or pharmaceutical acceptable derivative thereof, wherein said Cephalosporin exhibits altered pharmacokinetic parameters in a diabetic subject.